ADAM17 and COVID-19: After binding to ACE2 receptor the COVID-19/ACE2 complex generally takes entry to the host cell by endocytosis, those which are unable to take entry to host cell shed by ADAM Metallopeptidase Domain 17 (ADAM17) [146].